PharMerica Can't Ditch FCA Suit Over Altered Prescriptions

By Kevin Stawicki (February 6, 2020, 7:32 PM EST) -- PharMerica Corp. must face False Claims Act allegations it defrauded Medicare and Medicaid by billing for prescriptions with illegally altered dosages and that it retaliated against a whistleblowing former executive by coordinating a campaign to discredit her, a Pennsylvania federal judge ruled.

U.S. District Judge Cynthia M. Rufe on Wednesday denied Kentucky-based PharMerica's attempt to dismiss allegations it submitted false claims for government reimbursements for noncontrolled substances, controlled substances and brand-name drugs that were substituted for generics.

PharMerica, the second-largest nursing home pharmacy in the U.S., argued that there's no federal law governing the prescribing of noncontrolled drugs and that changing...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!